Preliminary gene therapy shows 75% reduction in Huntington's disease progression

A one-time experimental treatment shows unprecedented success in slowing Huntington's disease, according to UCL researchers. FDA review expected in 2026.

September 25, 2025

Top Stories

ABC News Live Presents